THE US Food and Drug
Administration (FDA) has released
a free Continuing Education Course
to help health care providers
understand biosimilars.
Biological products that
are “biosimilar” to, or
“interchangeable” with, an already approved
FDA biological product,
described as the “reference”
product, with similar access and
cost-saving motivations applying
to Australia’s Therapeutic Goods
Administration (TGA).The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.